Search Results - "Smith, Angela J"

OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study by Hanifin, Jon M., MD, Ellis, Charles N., MD, Frieden, Ilona J., MD, Fölster-Holst, Regina, MD, Stein Gold, Linda F., MD, Secci, Angelo, MD, Smith, Angela J., PA, Zhao, Cathy, PhD, Kornyeyeva, Elena, MD, PhD, Eichenfield, Lawrence F., MD

“…Background Peripheral leukocytes in patients with atopic dermatitis (AD) have elevated phosphodiesterase-4 activity, which is associated with production of…”
Get full text

Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes by Flowers, Christopher R, Costa, Luciano J, Pasquini, Marcelo C, Le-Rademacher, Jennifer, Lill, Michael, Shore, Tsiporah B, Vaughan, William, Craig, Michael, Freytes, Cesar O, Shea, Thomas C, Horwitz, Mitchell E, Fay, Joseph W, Mineishi, Shin, Rondelli, Damiano, Mason, James, Braunschweig, Ira, Ai, Weiyun, Yeh, Rosa F, Rodriguez, Tulio E, Flinn, Ian, Comeau, Terrance, Yeager, Andrew M, Pulsipher, Michael A, Bence-Bruckler, Isabelle, Laneuville, Pierre, Bierman, Philip, Chen, Andy I, Kato, Kazunobu, Wang, Yanlin, Xu, Cong, Smith, Angela J, Waller, Edmund K

“…Abstract Busulfan, cyclophosphamide, and etoposide (BuCyE) is a commonly used conditioning regimen for autologous stem cell transplantation (ASCT). This…”
Get full text

Expanding HIV care and training into Arkansas CHCs by Smith, Angela J

Get more information

John Beecher: An Activist Poet Chronicles an American Century by Smith, Angela J

“…John Beecher's legacy of poetry and non-fiction spans the pivotal social movements in America from 1920–1980. He was a great-great-nephew of the abolitionist…”
Get full text

Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase 2 Study and CIBMTR Outcomes by Flowers, Christopher R., Costa, Luciano J., Pasquini, Marcelo C, Le-Rademacher, Jennifer, Lill, Michael, Shore, Tsiporah B., Vaughan, William, Craig, Michael, Freytes, Cesar O., Shea, Thomas C., Horwitz, Mitchell E., Fay, Joseph W., Mineishi, Shin, Rondelli, Damiano, Mason, James, Braunschweig, Ira, Ai, Weiyun, Yeh, Rosa F., Rodriguez, Tulio E., Flinn, Ian, Comeau, Terrance, Yeager, Andrew M., Pulsipher, Michael A., Bence-Bruckler, Isabelle, Laneuville, Pierre, Bierman, Philip, Chen, Andy I., Kato, Kazunobu, Wang, Yanlin, Xu, Cong, Smith, Angela J., Waller, Edmund K.

“…Busulfan, cyclophosphamide and etoposide (BuCyE) is a commonly used conditioning regimen for autologous stem-cell transplantation (ASCT). This multicenter,…”
Get full text